GaDia SA is a Swiss startup that focuses on developing rapid Point-of-care predictive diagnostic tests for the detection and differentiation of healthcare-acquired infections. Their mission is to assist physicians in reducing the mortality rate of healthcare-acquired infections by providing accurate and relevant rapid diagnostic tests. Founded in 2019, the company is based in Switzerland, at the heart of the Swiss "Health Valley." GaDia SA's slogan, "Right information, right treatment, save time and lives," underscores their commitment to improving healthcare outcomes. With a specialization in rapid tests for infectious diseases, the company addresses a crucial need in the healthcare industry. GaDia SA's growth is evidenced not only by their innovative solutions but also by the expansion of their website. For more information, individuals are encouraged to contact [email protected] or visit the company's headquarters in the BioArk in Monthey, Switzerland. As of now, there is no public information available regarding their last investment or the investors involved.
There is no investment information
No recent news or press coverage available for GaDia SA.